Breast oncology Clinical Trials in Commack, NY
As of August 2026, 33 paid clinical trials are recruiting for Breast oncology in Commack, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Commack
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
35 clinical trials for Breast oncology
·Clear filters·A Study of a Side Effects and Resource Navigation Program for People With Cancer
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Factors Associated With Breast Cancer Risks and Outcomes
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
A Study of Surgery and Radiotherapy in People With Breast Cancer
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
A Study of Blood Pressure Control During Cancer Treatment
A Study of Language Interpretation Solutions for People With Breast Cancer
Lymphedema Surveillance Study
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
A Study of Revaree Plus in People With Breast Cancer
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Top Research Study Locations in Commack
Researchers run research studies in Commack, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Commack | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Breast Cancer | 65 |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Multiple Myeloma, Breast Cancer, Glioma | 39 |
| Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) | Non-Small Cell Lung Cancer, Breast Cancer, Anastomotic Leak | 17 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Breast Cancer, Prostate Cancer, Adenocarcinoma of the Breast | 15 |
| Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) | Acute Myeloid Leukemia, Bladder Cancer, Brain Tumor | 14 |
| Memorial Sloan Kettering Commack (Limited Protocol Activities) | Breast Cancer, Metastatic Breast Cancer, Brain Tumor | 11 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) | Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer | 10 |
| Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) | Gastric Adenocarcinoma, Gastric Cancer, Caregiver Burden | 9 |
| MSK Commack | Multiple Myeloma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 8 |
| Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) | Cancer, Bladder Cancer, Breast Cancer | 8 |
| Memorial Sloan Kettering Suffolk-Commack (Consent only) | High-risk Neuroblastoma, Metastatic Neuroblastoma, Neuroblastoma | 7 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) | Acute Myeloid Leukemia, AML, Acute Leukemia | 6 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) | Metastatic Breast Cancer, Bone Sarcoma, Breast Cancer | 6 |
| True North Neurology | Migraine, Acute Migraine, Acute Treatment of Migraine | 6 |
| Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities) | Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Metastatic Renal Cell Carcinoma | 5 |
| Memorial Sloan Kettering Suffolk - Commack | Brain Metastases, Brain Metastases, Adult, Lung Cancer | 5 |
| Memorial Sloan Kettering Suffolk - Commack (Consent Only) | Endometrial Cancer, Non-Muscle Invasive Bladder Cancer, Non-Small Cell Lung Cancer | 5 |
| Memorial Sloan Kettering Cancer Center @ Commack | Colorectal Cancer, Colorectal Carcinoma, Hodgkin Lymphoma | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) | Alveolar Soft Part Sarcoma, Extramammary Paget's Disease, Multiple Myeloma | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Breast Cancer | 4 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) | Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV | 4 |
| Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) | CNS Metastases, Central Nervous System Metastasis, Metastasis | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) | HNSCC, Head Cancer, Head Cancer Neck | 4 |
| Memorial Sloan Kettering Commack (All Protocol Activities) | Endometrial Cancer, Endometrial Cancer Stage I, Endometrioid Adenocarcinoma | 4 |
| Memorial Sloan Kettering Commack (Consent Only) | Adolescents and Young Adults With Cancer, Radiation Therapy, Breast Cancer | 4 |
Active & Upcoming Studies in Commack (2026)
Recruiting trials in Commack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (254 active studies)
- A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate · Phase 1 · Memorial Sloan Kettering Cancer Center
- A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer · Phase 2 · Memorial Sloan Kettering Cancer Center
Neurology & pain (9 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Pediatric (2 active studies)
- A Study of 177Lu-PSMA-617 in People With Gliomas · Phase 1 · Memorial Sloan Kettering Cancer Center
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Vaccines (1 active study)
HIV / STI (1 active study)
- A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma · Phase 2 · Memorial Sloan Kettering Cancer Center
Mental health & behavior (1 active study)
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · Memorial Sloan Kettering Cancer Center
Diabetes & metabolic (1 active study)
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · Phase 1 · Memorial Sloan Kettering Cancer Center
Common conditions studied in Commack
- Breast Cancer (28 active studies)
- Multiple Myeloma (14 active studies)
- Prostate Cancer (12 active studies)
- Acute Myeloid Leukemia (11 active studies)
- Endometrial Cancer (10 active studies)
- Non-Small Cell Lung Cancer (9 active studies)
Leading research sponsors in Commack
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Commack?
There are approximately 322 recruiting clinical trials in Commack, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Commack pay participants?
Most recruiting trials in Commack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Commack?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Commack?
The most common conditions under active study in Commack include Breast Cancer (28), Multiple Myeloma (14), Prostate Cancer (12), Acute Myeloid Leukemia (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Commack?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Commack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Commack?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Commack?
Recruiting research sites in Commack include Memorial Sloan Kettering Commack, Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Commack right now?
The largest active categories in Commack are Cancer & tumors (254), Neurology & pain (9), Pediatric (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.